Be sure to check our sister interview main ratings news website

SCLP

Hardman & Co

Scancell Holdings Preparing for next clinical studies

3rd October 2017

Scancell Holdings Plc (LON:SCLP) is a clinical stage pharmaceutical company developing two distinct flexible cancer immunotherapy platforms, each with broad applications. ImmunoBody is a DNA vaccine which stimulates high avidity

Hardman & Co

Scancell Holdings Plc SCIB development update

13th March 2017

Scancell Holdings Plc (LON:SCLP) is a clinical stage pharmaceutical company developing two distinct flexible cancer immunotherapy platforms, each with broad applications. ImmunoBody is a DNA vaccine which stimulates high avidity

Interviews

City of London Investment Group continuing its good performance (VIDEO)
City of London Investment Group continuing its good performance...
City of London Investment Group (LON:CLIG)...
Strix Group Green shoots and exciting expansion opportunities (VIDEO)
Strix Group Green shoots and exciting expansion opportunities (VIDEO)
Strix Group Plc (LON:KETL) CEO Mark...
H&T Group Unique opportunities for strong, profitable growth (VIDEO)
H&T Group Unique opportunities for strong, profitable growth (VIDEO)
H&T Group Plc (LON:HAT) is the...
Avation Plc taking advantage of the low CO2 pathway (VIDEO)
Avation Plc taking advantage of the low CO2 pathway...
Avation PLC (LON:AVAP) Executive Chairman Jeff...
Eden Research doorways open as Mevalone approved in 17 US states and Cedroz in 8 (VIDEO)
Eden Research doorways open as Mevalone approved in 17...
Eden Research Plc (LON:EDEN) CEO Sean Smith...

Funds

ALTEN, Bouygues Telecom Entreprises and Siemens France join forces
ALTEN, Bouygues Telecom Entreprises and Siemens France join forces
CLO market regains footing
CLO market regains footing
TEAM plc Mark Clubb ranked Spear’s ‘Top Recommended’ 2023 HNW wealth manager
TEAM plc Mark Clubb ranked Spear’s ‘Top Recommended’ 2023 HNW wealth manager
UK mortgage approvals rise in sign of stability returning
UK mortgage approvals rise in sign of stability returning
BlackRock Latin American Investment Trust total revenue return for the year up 59%
BlackRock Latin American Investment Trust total revenue return for the year up 59%
Tokyo stocks rise modestly
Tokyo stocks rise modestly

Presentations

Poolbeg Pharma Investment Case
Poolbeg Pharma Investment Case
Poolbeg Pharma (LON:POLB / OTCQB:POLBF) Investment Case...
Accrol Group Holdings Investor Presentation 2023
Accrol Group Holdings Investor Presentation 2023
Accrol Group Holdings (LON:ACRL) CEO Gareth...
Active Energy Group Plc (LON:AEG) CEO Michael Rowan talks us through the 2023 Business Update
Active Energy Group Plc (LON:AEG) CEO Michael Rowan talks us...
https://vimeo.com/789986536 Active Energy (LON:AEG, OTCQB:ATGVF),...
TEAM Plc’s Mark Clubb reviews 2022 and sets out the Company plans for 2023
TEAM Plc’s Mark Clubb reviews 2022 and sets out...
TEAM Plc (LON:TEAM) financial results for...
Active Energy Group overview with Michael Rowan CEO
Active Energy Group overview with Michael Rowan CEO
Active Energy Group Plc (LON:AEG) CEO...

Broker Talk

Challenger Energy Group “Uruguay holds significant potential”, Daniel Slater, Zeus Capital
Challenger Energy Group “Uruguay holds significant potential”, Daniel Slater, Zeus Capital
Fidelity Special Values: Making a case study for outperformance
Fidelity Special Values: Making a case study for outperformance
Fidelity China Special Situations: If you like China, why invest via FCSS?
Fidelity China Special Situations: If you like China, why invest via FCSS?
Pennant international “Outlook is clearly excellent” WH Ireland Nick Spoliar
Pennant international “Outlook is clearly excellent” WH Ireland Nick Spoliar
City of London Investment Group: Solid results in volatile markets
City of London Investment Group: Solid results in volatile markets
Avation buoyed by aviation recovery; “further momentum building” says Damian Brewer, Canaccord
Avation buoyed by aviation recovery; “further momentum building” says Damian Brewer, Canaccord

© 2022 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.